0000000000619877

AUTHOR

Daniel Prieto-alhambra

0000-0002-3950-6346

showing 4 related works from this author

Timing, Complications, and Safety of Tracheotomy in Critically Ill Patients With COVID-19

2021

Importance: The current coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented needs for invasive ventilation, with 10% to 15% of intubated patients subsequently requiring tracheotomy. Objective: To assess the complications, safety, and timing of tracheotomy performed for critically ill patients with COVID-19. Design, Setting, and Participants: This prospective cohort study assessed consecutive patients admitted to the intensive care unit (ICU) who had COVID-19 that required tracheotomy. Patients were recruited from March 16 to April 10, 2020, at a tertiary referral center. Exposures: A surgical tracheotomy was performed for all patients following recommended criteria for use…

Mechanical ventilationbusiness.industrymedicine.medical_treatmentHazard ratio030208 emergency & critical care medicineIntensive care unitlaw.invention03 medical and health sciences0302 clinical medicineTracheotomyOtorhinolaryngologyInterquartile rangelawAnesthesiamedicineIntubationSurgery030212 general & internal medicineProspective cohort studybusinessOriginal InvestigationCohort studyJAMA Otolaryngology–Head & Neck Surgery
researchProduct

The need for an independent evaluation of the COVID-19 response in Spain.

2020

Spain has been hit hard by COVID-19, with more than 300 000 cases, 28 498 confirmed deaths,1 and around 44 000 excess deaths, as of Aug 4, 2020.2 More than 50 000 health workers have been infected, and nearly 20 000 deaths were in nursing homes.3 With a population of 47 million, these data place Spain among the worst affected countries. Spain is also reported to have one of the best performing health systems in the world4 and ranks 15th in the Global Health Security index.5 So how is it possible that Spain now finds itself in this position?

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDisaster PlanningBetacoronavirusCorrespondencePandemicmedicineViral therapyHumansPandemicsIndependent evaluationbiologybusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseasebiology.organism_classificationVirologyPneumoniaHealthSpainMedicina Preventiva y Salud PúblicabusinessCoronavirus InfectionsDelivery of Health CareBetacoronavirus
researchProduct

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

2019

Summary Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. Introduction The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. This manuscript seeks to apply this in an international setting, taking additional account of further categorisation of increased risk of fracture, which may inform choice of therapeutic approach. Methods Clinical perspective and updated literature search. Results The following areas are reviewed: …

0301 basic medicinemedicine.medical_specialtyFRAXEndocrinology Diabetes and MetabolismeducationOsteoporosisPsychological interventioninhibitors of bone resorption030209 endocrinology & metabolismRisk AssessmentAnabolic agents03 medical and health sciencesTherapeutic approach0302 clinical medicineBone DensityRisk FactorsTreatment of osteoporosisInternal medicinemedicinefracture risk assessmentHumansanabolic agentsIntensive care medicineOsteoporosis PostmenopausalAgedAnabolic agents Fracture risk assessment FRAX Inhibitors of bone resorption Treatment of osteoporosisddc:616Postmenopausal womenbusiness.industryCorrectionFracture risk assessmentInhibitors of bone resorptionMiddle Agedtreatment of osteoporosismedicine.diseaseRheumatologyIncreased riskFemalePosition Paper030101 anatomy & morphologybusinessVery high riskAlgorithmsOsteoporotic FracturesFRAXOsteoporosis International
researchProduct

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinica…

2017

Objectives To gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), an area of high unmet clinical need. Methods The European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) organized a working group under the auspices of the International Osteoporosis Foundation (IOF) and the World Health Organization (WHO). Results This consensus guideline is intended to provide a reference tool for practice, and should allow for better standardization of the conduct of clinical trials in hand OA. Hand OA is …

medicine.medical_specialtyConsensusStandardizationHand JointsOsteoporosisOsteoarthritisDiseaseGuidelinesArticle03 medical and health sciences0302 clinical medicineClinical trialsRheumatologyOsteoarthritisHand osteoarthritismedicineHumans030212 general & internal medicineIntensive care medicineClinical trials; Guidelines; Hand osteoarthritis; Pharmacological treatment030203 arthritis & rheumatologyClinical Trials as Topicbusiness.industryclinical trialmedicine.diseaseClinical trialAnesthesiology and Pain MedicineResearch DesignExpert opinionAntirheumatic Agentshand osteoarthritibusinessguidelinePharmacological treatmentHand osteoarthritisConsensus guideline
researchProduct